GlassScriptPhysician profile
Jonathan Cordero Jimenez
NPI 1184011223
$15,560.81
in general payments reported to CMS, 2019-2025
29 companies · $3,909 in 2025
The $3,909 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $622 · 2021: $2,473 · 2022: $2,461 · 2023: $1,660 · 2024: $3,182 · 2025: $3,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,686 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,875 · Travel and Lodging: $1,177 · Education: $12.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,686.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,875.00 |
| Travel and Lodging | $1,176.61 |
| Education | $12.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,222.07 | 2019-2025 | Na, Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $4,089.67 | 2019-2025 | Avvigo Guidance System, Resonate El Icd Vr, General - Therapies |
| Abbott Laboratories | $1,656.90 | 2021-2025 | Optis, Dragonfly Opstar, Supera |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $984.23 | 2019-2025 | Lifevest |
| Philips North America LLC | $729.01 | 2023 | |
| Terumo Medical Corporation | $601.47 | 2022-2025 | Metacross Otw, Access, Navicross |
| Astrazeneca Pharmaceuticals LP | $413.41 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Pbg Puerto Rico LLC | $412.83 | 2019-2025 | |
| Amgen INC. | $403.59 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $281.75 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $250.00 | 2019-2024 | Eliquis, Camzyos |
| Penumbra, INC. | $222.00 | 2022 | |
| Asahi Intecc USA, INC. | $184.03 | 2025 | Asahi Peripheral Vascular Wires |
| Merck Sharp & Dohme LLC | $183.80 | 2021-2025 | Winrevair, Capvaxive |
| Cardiovascular Systems INC. | $148.00 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2022 | |
| Inari Medical, INC. | $124.88 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech USA, INC. | $117.19 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.79 | 2022-2025 | Jardiance |
| Abbvie INC. | $70.45 | 2025 | |
| Scpharmaceuticals INC. | $48.08 | 2025 | |
| Novartis Pharmaceuticals Corporation | $40.81 | 2021-2022 | |
| Akcea Therapeutics, INC. | $33.06 | 2019 | |
| Chiesi USA, INC. | $29.87 | 2019 | |
| W. L. Gore & Associates, INC. | $28.52 | 2024 | Gore Cardioform Septal Occluder |
| United Therapeutics Corporation | $21.35 | 2021 | |
| Biotronik INC. | $16.10 | 2022 | |
| Csl Behring | $15.05 | 2020 | |
| Pfizer INC. | $12.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cordero Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.